|
C3ORF26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.139650E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.82790000000144E-05 |
| Normal-vs-Stage2 |
3.969900E-04 |
| Normal-vs-Stage3 |
3.50650000000563E-05 |
| Normal-vs-Stage4 |
7.754400E-01 |
| Stage1-vs-Stage2 |
2.326600E-01 |
| Stage1-vs-Stage3 |
1.376020E-01 |
| Stage1-vs-Stage4 |
5.997700E-02 |
| Stage2-vs-Stage3 |
9.916000E-01 |
| Stage2-vs-Stage4 |
2.308500E-02 |
| Stage3-vs-Stage4 |
1.412090E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.167300E-04 |
| Normal-vs-AfricanAmerican |
1.721430E-01 |
| Normal-vs-Asian |
1.737620E-01 |
| Caucasian-vs-AfricanAmerican |
3.140200E-01 |
| Caucasian-vs-Asian |
9.744400E-01 |
| AfricanAmerican-vs-Asian |
4.927400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.161900E-04 |
| Normal-vs-Female |
2.456400E-02 |
| Male-vs-Female |
6.446000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.201000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.194100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.500600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.778850E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.998300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.018000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.073540E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.125200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.226410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.556340E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.885600E-02 |
| Normal-vs-Grade 2 |
2.24199999999675E-05 |
| Normal-vs-Grade 3 |
2.150100E-04 |
| Normal-vs-Grade 4 |
6.247400E-01 |
| Grade 1-vs-Grade 2 |
7.777800E-01 |
| Grade 1-vs-Grade 3 |
5.834600E-01 |
| Grade 1-vs-Grade 4 |
2.229600E-01 |
| Grade 2-vs-Grade 3 |
7.359000E-01 |
| Grade 2-vs-Grade 4 |
8.072000E-02 |
| Grade 3-vs-Grade 4 |
6.548200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.7162000000035E-05 |
| Normal-vs-ccB subtype |
1.116050E-02 |
| ccA subtype-vs-ccB subtype |
1.879760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.004540E-03 |
| Normal-vs-N1 |
2.046200E-01 |
| N0-vs-N1 |
6.967000E-01 |
|
|
